Form 144 - Report of proposed sale of securities:
SEC Accession No. 0001959173-24-004066
Filing Date
2024-06-03
Accepted
2024-06-03 13:05:50
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 4123
  Complete submission text file 0001959173-24-004066.txt   5583
Mailing Address 149 COMMONWEALTH DRIVE MENLO PARK CA 94025
Business Address 149 COMMONWEALTH DRIVE MENLO PARK CA 94025 650.688.8803
CORCEPT THERAPEUTICS INC (Subject) CIK: 0001088856 (see all company filings)

EIN.: 770487658 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 000-50679 | Film No.: 241012873
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O SUNESIS PHARMACEUTICALS, INC. 395 OYSTER POINT BLVD., SUITE 400 SOUTH SAN FRANCISCO CA 94080
Business Address
Swisher Daniel N JR (Reporting) CIK: 0001323113 (see all company filings)

Type: 144